Physician profile
John Lee
NPI 1740630995
$2,922.49
in general payments reported to CMS, 2019-2025
9 companies · $367 in 2025
The $367 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.88 · 2020: $271 · 2021: $546 · 2022: $752 · 2023: $408 · 2024: $564 · 2025: $367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,339.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,451.26 | 2021-2025 | Concertotm, Kyphon Express II Kyphopak Tray, Emprint |
| Penumbra, INC. | $346.54 | 2021-2022 | |
| Medtronic Vascular, INC. | $270.93 | 2020 | |
| Inari Medical, INC. | $240.65 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $224.13 | 2024-2025 | Spyglass Discover, General - Interventional Oncology |
| Sirtex Medical INC | $173.19 | 2025 | Sir-Spheres Microspheres |
| Terumo Medical Corporation | $167.80 | 2024-2025 | Azur Cx Detachable, Angio-Seal |
| Kala Pharmaceuticals, INC. | $30.20 | 2019-2021 | |
| Eisai INC. | $17.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.